Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
Primary eye care welcomes new GIRFT glaucoma guidance
Published on May 20, 2026
The organisations acknowledged the “positive direction” for shared care and fair funding of the enhanced clinical roles involved for primary eye care providers
Continue reading on website
Other news
Warby Parker Unveils First Intelligent Eyewear Design, Plans Fall Launch
May 20, 2026
NEW YORK—Warby Parker Inc. (NYSE: WRBY), a direct-to-consumer lifestyle brand, unveiled its first Intelligent Eyewear frame designed for all-day, everyday wear on Tuesday, May 19, at Google I/O 2026, according to an announcement from the company. Built in partnership with Google and Samsung, the frames feature Gemini and work with Android XR to provide contextual, real-time assistance. Wearers wil
Small NAION Risk from GLP-1 Therapy Not Yet Worth Drug Discontinuation, Experts Say
May 21, 2026
NAION is a rare condition, and the research has demonstrated that the overall risk for NAION remains low, even among patients taking semaglutide. Photo: Michael Trottini, OD, and Candice Tolud, OD. Click image to enlarge. The use of GLP-1 receptor agonist drugs has become increasingly common and will likely become more common with the recent FDA approval of oral semaglutide.
Primary eye care welcomes new GIRFT glaucoma guidance | Edcetera - Optometry